/Investor DB

LiveOak Ventures — 2021 Investments

5 investments dated 2021 · listed companies and verified rows first · show all

Infocyteinfocyte.comOct 2021acquired by DattoSEC filingmedium confidence

San Antonio, US

Christopher Gerritz(Executive Officer, Director)Ryan Morris(Executive Officer, Director)

BoardNick Hollis(Director)

Board seatVenu Shamapant· per SEC Form D · $1M raise · filed Oct 2021

Co-investorsToba Capital

FloorFoundfloorfound.comSeed · Feb 2021 · $4M

FloorFound is an operational sales platform that connects premium furniture brands with independent dealers, handling inventory management, dealer targeting, and transaction execution for closeout and recovery inventory.

B2B MarketplacesRetail TechSaaSLeander, US

Chris Richter(Executive Officer, Director)Mike Marcantonio(Director)

Co-investorsData Point CapitalFlybridge Capital PartnersNext Coast VenturesSchematic VenturesSpringTime Ventures

MedScoutmedscout.ioinPre-Seed · Jun 2021 · $800K

MedScout provides commercial intelligence and tools for medical device and healthcare technology companies to support their go-to-market strategies.

Data & InfrastructureEnterprise SoftwareHealthtechMedical DevicesSaaSSales Tech

Co-investorsAlumni VenturesCapital FactoryFulcrum Equity PartnersStage 2 Capital

SchooLinksschoolinks.comin𝕏Mar 2021

SchooLinks is a college and career readiness platform for K-12 school districts, helping counselors track student progress, manage caseloads, and meet state compliance and reporting requirements.

EdTechSaaSAustin, US

Katie Fang(Executive Officer, Director)inCharles Thornburgh(Director)in

BoardKrishna Srinivasan(Director)in

Co-investorsJuvo VenturesSJF VenturesSusquehanna Growth Equity

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Intrigue Corporation

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.